Values of spearman rho correlations: | IL-6 | TNF-α | Glutamate | ||||
---|---|---|---|---|---|---|---|
IL-6 | IL-6 | TNF-α | TNF-α | Glu | Glu | ||
<12 h | 72 h | <12 h | 72 h | <12 h | 72 h | ||
Clinical severity (APACHE II) | All patients | 0.261 | 0.326** | 0,130 | 0,155 | −0.076 | −0.029 |
−0.061 | 0.484** | −0,085 | 0,068 | 0.421* | −0.193 | ||
Large infarcts | 0.630*** | 0.433 | 0.244 | 0.347 | −0.052 | 0.149 | |
−0.369 | 0.197 | −0,821 | −0,462 | −0.350 | −0.727** | ||
Medium infarcts | −0.066 | 0.241 | 0.190 | 0.044 | −0.042 | −0.007 | |
0.261 | 0.759** | - | 0.400 | 0.374 | 0.410 | ||
Stroke severity (NIHSS) | All patients | 0.068 | 0.497*** | 0.312 | 0.247 | 0.193 | 0.261* |
- | - | −0.488 | −0.488 | - | - | ||
Large infarcts | 0.247 | 0.020 | 0.388 | 0.433 | 0.165 | −0.013 | |
- | - | −0.866 | −0.866 | - | - | ||
Medium infarcts | −0.223 | 0.505*** | −0.023 | −0.108 | 0.217 | 0.371** | |
- | - | −0.866 | −0.866 | - | - | ||
Volume of infarct§ | All patients | 0.207 | 0.290** | 0.476** | 0.275 | 0.120 | 0.151 |
Large infarcts | 0.398 | 0.299 | 0.592* | 0364 | 0.325 | 0.324 | |
Medium infarcts | 0.069 | −0.113 | 0.097 | 0.178 | 0.001 | 0.001 | |
Clinical outcome: 3-months mRS | All patients | 0.230 | 0.444*** | 0.352* | 0.150 | 0.101 | 0.006 |
- | - | 0.546 | −0.095 | - | - | ||
Large infarcts | 0.453* | 0.455 | 0.370 | 0.283 | 0.235 | 0.295 | |
- | - | 0.105 | 0.316 | - | - | ||
Medium infarcts | 0.042 | 0.273 | 0.338 | 0.120 | −0.023 | −0.080 | |
- | - | 0.316 | −0.738 | - | - | ||
Clinical outcome: 3-months Barthel index | All patients | −0.121 | −0.245 | −0.152 | −0.109 | −0.164 | −0.017 |
−0.492* | −0.303 | −0.536 | −0.009 | 0.092 | 0.433* | ||
Large infarcts | −0.366 | −0.366 | 0.119 | −0.444 | −0.268 | 0.000 | |
−0.449 | −0.338 | −0.200 | −0.300 | −0.570 | 0.591* | ||
Medium infarcts | −0.053 | −0.078 | −0.262 | 0.168 | −0.042 | 0.006 | |
−0.702* | 0.025 | −0.316 | 0.738 | 0.368 | −0.495 |